Peter Radovich
President bij MIRUM PHARMACEUTICALS, INC.
Vermogen: 728 807 $ op 31-03-2024
Profiel
Peter Radovich is the President & Chief Operating Officer at Mirum Pharmaceuticals, Inc. He previously worked as the Senior Director & VP-Program Leadership at Onyx Pharmaceuticals, Inc. from 2004 to 2006.
He also served as an Independent Director at Rain Oncology, Inc. from 2018 to 2024.
Additionally, Mr. Radovich worked as a Principal at Chiron Corp.
from 2004 to 2006 and as the Senior Vice President-Operations at Global Blood Therapeutics, Inc. from 2014 to 2020.
He holds an MBA from the University of Washington and an undergraduate degree from Texas Christian University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-03-2024 | 29 013 ( 0.06% ) | 728 807 $ | 31-03-2024 |
Actieve functies van Peter Radovich
| Bedrijven | Functie | Begin |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | President | 16-01-2024 |
Eerdere bekende functies van Peter Radovich
| Bedrijven | Functie | Einde |
|---|---|---|
| RAIN ONCOLOGY INC. | Director/Board Member | 25-01-2024 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Operating Officer | 01-04-2020 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director/Board Member | 01-09-2006 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01-01-2006 |
Opleiding van Peter Radovich
| University of Washington | Masters Business Admin |
| Texas Christian University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
